Literature DB >> 1412093

Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery.

G M Ainslie1, J A Solomon, E D Bateman.   

Abstract

BACKGROUND: Lymphocytes have a central role in human defences against mycobacteria. A study was designed to assess the relation between lymphocyte responses and clinical pattern of disease, nutrition and recovery during treatment in patients with tuberculosis.
METHODS: Lymphocyte numbers and subsets (on the basis of CD3, CD4, and CD8 monoclonal antibodies) were measured in peripheral blood and, where appropriate, bronchoalveolar lavage or pleural fluid of patients with different forms of pulmonary tuberculosis. Eleven had localised pulmonary tuberculosis, 18 miliary tuberculosis and seven a tuberculous pleural effusion.
RESULTS: CD4 lymphocytes were found in greatly increased numbers in pleural fluid and were relatively depleted in the blood. Lymphocyte numbers in bronchoalveolar lavage fluid varied widely in localised pulmonary and miliary tuberculosis but were highest in lavage fluid from patients with miliary tuberculosis. This was due to an increase in CD8 lymphocytes, which were also increased in the blood. Lymphocyte numbers bore no relation to nutrition, symptom duration, or radiographic profusion scores. In miliary tuberculosis the time taken for the chest radiograph to clear (mean (SD) 17.6 (7.8) weeks) correlated with lymphocyte numbers in lavage fluid, especially CD8 cells (r = 0.74), but not with the patients' age or nutrition. After 8 weeks' treatment, total and CD4 lymphocyte numbers in lavage fluid showed a substantial increase.
CONCLUSION: The association of CD8 cells with delayed recovery is compatible with suppression of the antimycobacterial action of macrophages. The switch to predominance of CD4 cells in lavage fluid during successful treatment supports the view that they may have a role in eliminating mycobacteria.

Entities:  

Mesh:

Year:  1992        PMID: 1412093      PMCID: PMC463860          DOI: 10.1136/thx.47.7.513

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  33 in total

1.  Pleural fluid and peripheral blood lymphocyte function in tuberculosis.

Authors:  J J Ellner
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

2.  Mycobacterial antigen-specific human T-cell clones secreting macrophage activating factors.

Authors:  R Matthews; A Scoging; A D Rees
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

3.  Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection.

Authors:  G A Rossi; B Balbi; F Manca
Journal:  Am Rev Respir Dis       Date:  1987-09

4.  Determination of the T-cell subset producing gamma-interferon in tuberculous pleural effusion.

Authors:  K Shimokata; H Kishimoto; E Takagi; H Tsunekawa
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

5.  Immune status in tuberculosis and response to treatment.

Authors:  J K Onwubalili; G M Scott
Journal:  Tubercle       Date:  1988-06

6.  Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes.

Authors:  P Katz; R A Goldstein; A S Fauci
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

7.  Factors influencing the cellular response in bronchoalveolar lavage and peripheral blood of patients with pulmonary tuberculosis.

Authors:  R Dhand; A De; N K Ganguly; N Gupta; S Jaswal; S K Malik; K K Kohli
Journal:  Tubercle       Date:  1988-09

8.  Specificity of proliferative response of human CD8 clones to mycobacterial antigens.

Authors:  A Rees; A Scoging; A Mehlert; D B Young; J Ivanyi
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

9.  Production of a suppressor factor by human adherent cells treated with mycobacteria.

Authors:  A A Wadee; R Sher; A R Rabson
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

10.  The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes.

Authors:  T H Ottenhoff; B K Ab; J D Van Embden; J E Thole; R Kiessling
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  20 in total

1.  In situ activation of helper T cells in the lung.

Authors:  B Raju; C F Tung; D Cheng; N Yousefzadeh; R Condos; W N Rom; D B Tse
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle.

Authors:  J M Pollock; D A Pollock; D G Campbell; R M Girvin; A D Crockard; S D Neill; D P Mackie
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  38 000 MW antigen-specific major histocompatibility complex class I restricted interferon-gamma-secreting CD8+ T cells in healthy contacts of tuberculosis.

Authors:  R J Wilkinson; X Zhu; K A Wilkinson; A Lalvani; J Ivanyi; G Pasvol; H M Vordermeier
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 4.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

5.  Cellular profile of bronchoalveolar lavage fluid in pulmonary tuberculosis.

Authors:  S Swaminathan; P Venkatesan; K Sankaran; R Prabhakar; V K Vijayan; N Somu; D Vijayasekaran
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

6.  Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.

Authors:  D S S Rodrigues; E A S Medeiros; L Y Weckx; W Bonnez; R Salomão; E G Kallas
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

7.  Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1(+) gamma delta T cells.

Authors:  Hilary E Kennedy; Michael D Welsh; David G Bryson; Joseph P Cassidy; Fiona I Forster; Christopher J Howard; Robert A Collins; John M Pollock
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis.

Authors:  C T Yu; C H Wang; T J Huang; H C Lin; H P Kuo
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

9.  Altered expression of CD11/CD18 on the peripheral blood phagocytes of patients with tuberculosis.

Authors:  R J Yassin; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.

Authors:  Tan N Doan; Pengxing Cao; Theophilus I Emeto; James M McCaw; Emma S McBryde
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.